These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8902158)

  • 41. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
    Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A
    Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
    Thomas GS; Cromwell WC; Ali S; Chin W; Flaim JD; Davidson M
    J Am Coll Cardiol; 2013 Dec; 62(23):2178-84. PubMed ID: 24013058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus.
    Sprandel MC; Hueb WA; Segre A; Ramires JA; Kalil-Filho R; Maranhão RC
    Cardiovasc Diabetol; 2015 Aug; 14():107. PubMed ID: 26268997
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced regulatory capacity of low density lipoproteins from patients with coronary artery disease.
    Shi F; Jouni ZE; McNamara DJ
    Atherosclerosis; 1991 Dec; 91(3):217-27. PubMed ID: 1665063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS).
    Vakkilainen J; Steiner G; Ansquer JC; Aubin F; Rattier S; Foucher C; Hamsten A; Taskinen MR;
    Circulation; 2003 Apr; 107(13):1733-7. PubMed ID: 12665498
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease.
    Genest J; McNamara JR; Ordovas JM; Jenner JL; Silberman SR; Anderson KM; Wilson PW; Salem DN; Schaefer EJ
    J Am Coll Cardiol; 1992 Mar; 19(4):792-802. PubMed ID: 1531990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Remnant-like particle cholesterol levels in Korean patients with coronary artery disease and non-insulin dependent diabetes mellitus.
    Song J; Park H; Hong SH; Lee HK; Park YB; Kim JQ
    Clin Chem Lab Med; 2000 May; 38(5):427-32. PubMed ID: 10952226
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolism of cholesterol and low- and high-density lipoproteins in primary biliary cirrhosis: cholesterol absorption and synthesis related to lipoprotein levels and their kinetics.
    Gylling H; Färkkilä M; Vuoristo M; Miettinen TA
    Hepatology; 1995 Jan; 21(1):89-95. PubMed ID: 7806174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis.
    Schmidt SB; Wasserman AG; Muesing RA; Schlesselman SE; Larosa JC; Ross AM
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1459-62. PubMed ID: 3923814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apolipoprotein A-I containing lipoproteins in coronary artery disease.
    Puchois P; Kandoussi A; Fievet P; Fourrier JL; Bertrand M; Koren E; Fruchart JC
    Atherosclerosis; 1987 Nov; 68(1-2):35-40. PubMed ID: 3120739
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The distribution of squalene and non-cholesterol sterols in lipoproteins in type 2 diabetes.
    Simonen PP; Gylling H; Miettinen TA
    Atherosclerosis; 2007 Sep; 194(1):222-9. PubMed ID: 16963050
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease.
    Mudd JO; Borlaug BA; Johnston PV; Kral BG; Rouf R; Blumenthal RS; Kwiterovich PO
    J Am Coll Cardiol; 2007 Oct; 50(18):1735-41. PubMed ID: 17964036
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
    Rasouli M; Kiasari AM; Mokhberi V
    Clin Chem Lab Med; 2006; 44(8):1015-21. PubMed ID: 16879071
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.
    Kim HK; Chang SA; Choi EK; Kim YJ; Kim HS; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS
    Int J Cardiol; 2005 Jun; 101(3):435-40. PubMed ID: 15907412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased large VLDL and small LDL particles are related to lower bilirubin in Type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Lefrandt JD
    Clin Biochem; 2014 Nov; 47(16-17):170-5. PubMed ID: 25149194
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study.
    März W; Scharnagl H; Winkler K; Tiran A; Nauck M; Boehm BO; Winkelmann BR
    Circulation; 2004 Nov; 110(19):3068-74. PubMed ID: 15505088
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein.
    Karpe F; Tornvall P; Olivecrona T; Steiner G; Carlson LA; Hamsten A
    Atherosclerosis; 1993 Jan; 98(1):33-49. PubMed ID: 8457249
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of low plasma high density lipoprotein (HDL)-cholesterol concentration with documented coronary artery disease in males with non-insulin dependent diabetes mellitus.
    Fuh MM; Shieh SM
    Horm Metab Res; 1987 Jun; 19(6):267-70. PubMed ID: 3623416
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease.
    Genest JJ; Bard JM; Fruchart JC; Ordovas JM; Wilson PF; Schaefer EJ
    Atherosclerosis; 1991 Oct; 90(2-3):149-57. PubMed ID: 1684707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Levels of serum lipids, apolipoproteins A-I and B and pseudocholinesterase activity and their discriminative values in patients with coronary by-pass operation.
    Lehtonen A; Marniemi J; Inberg M; Maatela J; Alanen E; Niittymäki K
    Atherosclerosis; 1986 Feb; 59(2):215-21. PubMed ID: 3083832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.